Alzheimer's disease & dementia

New Alzheimer therapy passes another important test

The Alzheimer drug candidate PRI-002 developed at Forschungszentrum Jülich has successfully completed Phase I of clinical research involving healthy volunteers. When administered daily over a period of four weeks, the active ...

Alzheimer's disease & dementia

Can Alzheimer's be stopped years before it starts?

Researchers at the Keck School of Medicine of USC are tackling the sixth-leading cause of death in the United States—Alzheimer's disease—with a new study that intervenes decades before the disease develops.

Alzheimer's disease & dementia

New drug SAK3 may offer hope to Alzheimer's disease patients

Acetylcholine is a neurotransmitter in the brain that plays an important role in controlling attention and cognition. Acetylcholine system dysfunction is believed to be one of the causes of Alzheimer's disease (AD) and vascular ...

Alzheimer's disease & dementia

Hope sparked by new vaccine for Alzheimer's

Brain research has made unprecedented progress over the years, with Europe at the forefront of scientific advances. But more can be done. This comes from Alzheimer's Disease International who issued their report on the Global ...

page 36 from 38